Table 6.
Enzyme | HGNC approved gene symbol | Cytogenic location | Subcellular location | Pathway/function | Magnesium as a further cofactor | Functions of metabolic products and resulting other pathways intermediates | Clinical implication in deficiency states |
---|---|---|---|---|---|---|---|
TK EC 2.2.1.1 |
TKT | 3p21.1 | Cytosol, extracellular exosome, nucleus, peroxisome, vesicles | Pentose phosphate pathway | Yes | Substrates in the glycolytic pathways Generation of d-ribose-5-P → Nucleotide synthesis → RNA/DNA synthesis NADPH as a reducing agent for fatty acid and acetylcholine synthesis, maintenance of myelin sheaths Aromatic amino acid synthesis |
↓ energy supply ↓ nucleotide synthesis ↓ fatty acid synthesis → facilitating demyelination ↑oxidative stress Amino acid imbalance |
TK protein 1 EC 2.2.1.1 |
TKTL 1 | Xq28 | Cytosol, nucleus | As TK | Yes | May structurally alter TPP to change TPP affinity for TK78 | Unclear |
PDHG EC 1.2.4.1 |
PDHA1 | Xp22.12 | Mitochondrion, nucleus, PDHG complex (GO:0045254)a | Glycolysis (rate-limiting co-factor) | Yes | Fatty acid, ketone bodies and acetylcholine synthesis, maintenance of myelin sheaths Generation of Acetyl CoA Generation of citrate, the first component in the TCA cycle |
↓ fatty acid synthesis → demyelination ↓ Energy (ATP) production Leigh phenotype |
α-ketoglutarate dehydrogenase α-KGDH/OGDC EC 1.2.4.2 |
OGDH | 7p13 | Mitochondrion, nucleus, OGDC (GO: 0045252)a | TCA (citric acid) cycle | Yes | Energy production (ATP) Generation of succinyl CoA |
↑ nitric oxide and peroxidase activity →oxidative stress ↓ energy production Lactate acidosis and ↑focal extracellular glutamate → oedema → excitotoxicity → BBB permeability → neuronal death |
BCKDH E1 subunit α EC 1.2.4.4 |
BCKDHA | 19q13.2 | Mitochondrion | Degradation of branched chain amino acids, valine, leucine and isoleucine, facilitating the oxidative decarboxylation step | Yes | Isobuturyl CoA, α-methylbuturyl CoA, isovaleryl CoA → acetyl CoA, acetoacetate, succinyl CoA → Fatty acid, ketone bodies and acetylcholine synthesis, maintenance of myelin sheaths |
↓ fatty acid synthesis → demyelination ↑ Valine, leucine and isoleucine and corresponding α-ketoacids → maple syrup urine disease |
2-hydroxyacyl CoA lyase 1 (HACL1) EC 4.1.-.- |
HACL1 | 3p25.1 | Cytosol, peroxisomes | Oxidation of 3-methyl branched fatty acids such as phytanic acid and 2-hydroxy fatty acids (α-oxidation) | Yes | Formate → CO2 | Peroxisome biogenesis defects → impeding the breakdown of certain nutrients including amino acids degeneration and β-oxidation of fatty acids ↑ phytanic acid → Refsum disease |
Note that this term represents a location and not a function.
ATP, adenosine triphosphate; BCKDH, branched chain α-keto acid dehydrogenase; Co A, coenzyme A; EC, Enzyme Commission numbers; GO, gene ontology; HGNC, HUGO Gene Nomenclature Committee; NADPH, nicotinamide adenine dinucleotide phosphate (hydrogenated, i.e. reduced form); ODGC, oxoglutarate dehydrogenase complex; P, phosphate; PDHG, pyruvate dehydrogenase; TCA cycle, tricarboxylic acid cycle; TK, transketolase; TPP, thiamine pyrophosphate.